Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future. Volkow, Amer J Psychiatry. https://pubmed.ncbi.nlm.nih.gov/38706329/
Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. Jones et al., JAMA Intern Med. https://pubmed.ncbi.nlm.nih.gov/38884975/
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021. Jones et al., JAMA Psychiatry. https://pubmed.ncbi.nlm.nih.gov/38717781/
A Content Analysis of Legal Policy Responses to Xylazine in the Illicit Drug Supply in the United States. Sugarman et al., Int J Drug Policy. https://pubmed.ncbi.nlm.nih.gov/38852335/
Breaking Free From the "War on Drugs": Examples From Three Leader States. Davis and Lieberman., J Law Med Ethics. https://pubmed.ncbi.nlm.nih.gov/38995244/
Comparing harm reduction and overdose response services between community-based and public health department syringe service programmes using a national cross-sectional survey. Ray et al., Lancet Reg Health Am. https://pubmed.ncbi.nlm.nih.gov/38745887/
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020. Tookes et al., Int J Drug Policy. https://pubmed.ncbi.nlm.nih.gov/38071932/
Use of Medications for Opioid Use Disorder and Child Welfare Outcomes. Muhar et al., JAMA Health Forum. https://pubmed.ncbi.nlm.nih.gov/38995635/
Pregnancy and Postpartum Drug Overdose Deaths in the US Before and During the COVID-19 Pandemic. Han et al., JAMA Psychiatry. https://pubmed.ncbi.nlm.nih.gov/37991773/
Punitive Legal Responses to Prenatal Drug Use in the United States: A Survey of State Policies and Systematic Review of their Public Health Impacts. Bruzelius et al., International Journal of Drug Policy. https://pubmed.ncbi.nlm.nih.gov/38484529/
Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023. Savitz et al., Mayo Clin Proc Innov Qual Outcomes. https://pubmed.ncbi.nlm.nih.gov/38841599/